AU2003902260A0 - Dpp-iv inhibitor - Google Patents

Dpp-iv inhibitor

Info

Publication number
AU2003902260A0
AU2003902260A0 AU2003902260A AU2003902260A AU2003902260A0 AU 2003902260 A0 AU2003902260 A0 AU 2003902260A0 AU 2003902260 A AU2003902260 A AU 2003902260A AU 2003902260 A AU2003902260 A AU 2003902260A AU 2003902260 A0 AU2003902260 A0 AU 2003902260A0
Authority
AU
Australia
Prior art keywords
dpp
iv inhibitor
inhibitor
iv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003902260A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to AU2003902260A priority Critical patent/AU2003902260A0/en
Publication of AU2003902260A0 publication Critical patent/AU2003902260A0/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
AU2003902260A 2003-05-09 2003-05-09 Dpp-iv inhibitor Abandoned AU2003902260A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003902260A AU2003902260A0 (en) 2003-05-09 2003-05-09 Dpp-iv inhibitor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2003902260A AU2003902260A0 (en) 2003-05-09 2003-05-09 Dpp-iv inhibitor
PCT/JP2004/006568 WO2004099185A1 (en) 2003-05-09 2004-05-10 2-cyanopyrrolidine derivatives and their use as dpp-iv inhibitors

Publications (1)

Publication Number Publication Date
AU2003902260A0 true AU2003902260A0 (en) 2003-05-29

Family

ID=31501130

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003902260A Abandoned AU2003902260A0 (en) 2003-05-09 2003-05-09 Dpp-iv inhibitor

Country Status (2)

Country Link
AU (1) AU2003902260A0 (en)
WO (1) WO2004099185A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2375625T3 (en) 2004-02-05 2012-03-02 Kyorin Pharmaceutical Co., Ltd. Bicyclo ester derivatives.
ES2376351T5 (en) 2005-09-14 2014-07-15 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase for treating diabetes
CN102675221A (en) 2005-09-16 2012-09-19 武田药品工业株式会社 Intermediate in method for preparing pyrimidinedione derivative
AU2007224066B2 (en) * 2006-03-08 2011-10-27 Kyorin Pharmaceutical Co., Ltd. Method for producing aminoacetylpyrrolidinecarbonitrile derivative and production intermediate thereof
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7728146B2 (en) 2006-04-12 2010-06-01 Probiodrug Ag Enzyme inhibitors
EP2035395A2 (en) * 2006-06-27 2009-03-18 Glenmark Pharmaceuticals S.A. Novel processes for the preparation of dpp iv inhibitors
WO2008055945A1 (en) 2006-11-09 2008-05-15 Probiodrug Ag 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
WO2008065141A1 (en) 2006-11-30 2008-06-05 Probiodrug Ag Novel inhibitors of glutaminyl cyclase
WO2008114857A1 (en) 2007-03-22 2008-09-25 Kyorin Pharmaceutical Co., Ltd. Method for producing aminoacetylpyrrolidinecarbonitrile derivative
US9656991B2 (en) 2007-04-18 2017-05-23 Probiodrug Ag Inhibitors of glutaminyl cyclase
AU2009307884B2 (en) 2008-10-22 2014-07-31 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
AU2009309037A1 (en) 2008-10-31 2010-05-06 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
EP2475428B1 (en) 2009-09-11 2015-07-01 Probiodrug AG Heterocylcic derivatives as inhibitors of glutaminyl cyclase
US8895596B2 (en) 2010-02-25 2014-11-25 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
ES2586231T3 (en) 2010-03-03 2016-10-13 Probiodrug Ag Glutaminyl cyclase inhibitors
CN102791704B (en) 2010-03-10 2015-11-25 前体生物药物股份公司 Glutaminyl cyclase (qc, ec 2.3.2.5) heterocyclic inhibitors
JP5945532B2 (en) 2010-04-21 2016-07-05 プロビオドルグ エージー Benzimidazole derivatives as inhibitors of glutaminyl cyclase
CN103476258B (en) 2011-02-25 2017-04-26 默沙东公司 Antidiabetic agents as novel cyclic derivatives azabenzimidazole
US8530670B2 (en) 2011-03-16 2013-09-10 Probiodrug Ag Inhibitors
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2014020462A1 (en) * 2012-08-01 2014-02-06 Alembic Pharmaceuticals Limited Improved process for preparation of vildagliptin intermediate
KR20150036245A (en) 2012-08-02 2015-04-07 머크 샤프 앤드 돔 코포레이션 Antidiabetic tricyclic compounds
CN103351320A (en) * 2013-06-17 2013-10-16 张家港威胜生物医药有限公司 Preparation method of (S)-1-(2-chloroacetyl)-pyrrolidine-2-formamide
EP3461819A1 (en) 2017-09-29 2019-04-03 Probiodrug AG Inhibitors of glutaminyl cyclase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030060997A1 (en) * 2001-06-27 2003-03-27 Ilyes Timothy J. Seat belt force or tension sensor with programmable hall effect sensor

Also Published As

Publication number Publication date
WO2004099185A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
EP1682493B8 (en) Amidoacetonitrile derivatives
AU2003268680A1 (en) Binding tool
TWI297011B (en) Dpp-iv inhibitors
AU2003262244A1 (en) Nitrogen-containing compounds
AU2003222055A1 (en) Kinase inhibitors
AU2003249442A1 (en) Kinase inhibitors
AU2003222140A1 (en) Pallet
AU2003211931A1 (en) Jnk inhibitor
AU2003266949A1 (en) Compounds
AU2003233465A1 (en) Structural member
AU2003239909A1 (en) Enhanced-service provision
PL373146A1 (en) Pyridazinone-derivatives as pde4 inhibitors
AU2003265349A1 (en) Pyrrolotriazine kinase inhibitors
AU2003249738A1 (en) Ostoscope
AU2003297193A1 (en) Meta-web
AU2003273433A1 (en) Cartridge-operated coffee-machine
AU2003231825A1 (en) Fluoro-silane-oligomer composition
AU2003221098A1 (en) Oligofluorenylene compounds
AU2003217234A1 (en) Modulator- amplifier
AU2003258045A1 (en) Novel gamma-lactams as beta-secretase inhibitors
AU2003224111A1 (en) Substituted pyrazolo-pyrimidine-4-ones
AU2003253880A1 (en) Novel kinases
AU2003211362A1 (en) N-hydroxycarboxamide derivative
AU2003207881A1 (en) Dipeptidyl peptidase inhibitors
AU2003278088A1 (en) Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors